Health Care · Pharmaceutical Preparations · NYSE · CIK 1174940 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.50Day −0.06%Mkt cap $2M1Y −63.5%Off 52W high −65.7%Vol (1Y) 70.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,536 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest17.4% of sh out |
| Days to cover28.7d |
| 13F net flow (QoQ)+0.06% |
| Top-10 13F concentration99.9% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$37,653 |
| Earnings (TTM)-$9.8M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−36.3% |
| 1Y−63.5% |
| 3Y−99.6% |
| 5Y−100.0% |
| Since incept. (ann.)−70.9% |
Total return through 2026-07-29 · series begins 2020-06-02. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)70.0% |
| Ann. volatility (3Y)121.5% |
| Sharpe (1Y)−1.13 |
| Sharpe (3Y)−0.86 |
| Max drawdown (1Y)−65.0% |
| Max drawdown (3Y)−99.8% |
| Beta (3Y vs SPY)1.71 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 65,072 | $36,445 | 1.44% | new |
| Pathstone Holdings, LLC | 55,001 | $30,807 | 1.22% | new |
| TWO SIGMA SECURITIES, LLC | 20,343 | $11,394 | 0.45% | new |
| HRT FINANCIAL LP | 18,672 | $10,000 | 0.41% | new |
| Virtu Financial LLC | 17,575 | $10,000 | 0.39% | new |
| UBS Group AG | 5,205 | $2,915 | 0.12% | +117.4% |
| Tower Research Capital LLC (TRC) | 4,548 | $2,547 | 0.10% | −0.1% |
| Ameritas Advisory Services, LLC | 2,000 | $1,120 | 0.04% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | −$0.51 | — | — | — |
| 2025-09-30 | 2025-11-07 | −$1.96 | — | — | — |
| 2025-06-30 | 2025-08-08 | −$3.10 | — | — | — |
| 2025-03-31 | 2025-05-09 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
